Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +59.9% | -22.9% | 1 / 3 | +39.6% | +0.04 pp | +0.06 pp | +9.8% | 4.99 | 7.54 | 12.585 | +39,6% | 56,3 | +59,9% | 7.54 | 4.07 | +85,3% |
| Pts | 8 | 0 | 4 | 12 | 8 | 8 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 43.500 (close price on 2026-10-19)EPS (TTM): 5.769
Financial charts
1.Revenue & growth
VND bn12.585Q2/26
1.Revenue & growth
VND bn12.585Q2/26
2.Profit & growth
VND bn56,7Q2/26
3.Profit mix (Penman)
VND bn132Q2/26
4.Margins & cost structure
%4.5%Q2/26
5.Returns & cash cycle
% · days4.0%Q2/26
6.Earnings quality & cash
VND bn-658Q2/26
7.Asset structure
VND bn7.299Q2/26
8.Funding & debt health
VND bn · times7.299Q2/26
9.Revenue backlog
VND bn42,4Q2/26
10.Valuation
times · %7,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.779Q2/26
Adjusted EPS growth, latest quarter
60.9%
Average adjusted EPS growth, 3 quarters
-22.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26